Abstract
The previous studies all focus on the effect of probiotics and antibiotics on infection after liver transplantation. Here, we focus on the effect of gut microbiota alteration caused by probiotics and antibiotics on hepatic damage after allograft liver transplantation. Brown-Norway rats received saline, probiotics, or antibiotics via daily gavage for 3 weeks. Orthotopic liver transplantation (OLT) was carried out after 1 week of gavage. Alteration of the intestinal microbiota, liver function and histopathology, serum and liver cytokines, and T cells in peripheral blood and Peyer’s patch were evaluated. Distinct segregation of fecal bacterial diversity was observed in the probiotic group and antibiotic group when compared with the allograft group. As for diversity of intestinal mucosal microbiota and pathology of intestine at 2 weeks after OLT, antibiotics and probiotics had a significant effect on ileum and colon. The population of Lactobacillus and Bifidobacterium in the probiotic group was significantly greater than the antibiotic group and the allograft group. The liver injury was significantly reduced in the antibiotic group and the probiotic group compared with the allograft group. The CD4/CD8 and Treg cells in Peyer’s patch were decreased in the antibiotic group. The intestinal Treg cell and serum and liver TGF-β were increased markedly while CD4/CD8 ratio was significantly decreased in the probiotic group. It suggested that probiotics mediate their beneficial effects through increase of Treg cells and TGF-β and deduction of CD4/CD8 in rats with acute rejection (AR) after OLT.
Similar content being viewed by others
Abbreviations
- OLT:
-
Orthotopic liver transplantation
- AR:
-
Acute rejection
References
Barkholt L, Ericzon BG, Tollemar J, Malmborg AS, Ehrnst A, Wilczek H, Andersson J (1993) Infections in human liver recipients: different patterns early and late after transplantation. Transpl Int 6:77–84
Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L (2004) Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl 10:886–897
Romero FA, Razonable RR (2011) Infections in liver transplant recipients. World J Hepatol 3:83–92
So AD, Gupta N, Cars O (2010) Tackling antibiotic resistance. BMJ 340:c2071
Guarner F, Malagelada JR (2003) Gut flora in health and disease. Lancet 361:512–519
Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, Bengmark S, Neuhaus P (2005) Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation—a randomized, double-blind trial. Am J Transplant 5:125–130
Rayes N, Seehofer D, Hansen S, Boucsein K, Muller AR, Serke S, Bengmark S, Neuhaus P (2002) Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 74:123–127
Xie YR, Luo ZB, Li ZF, Deng M, Liu H, Zhu B, Ruan B, Li LJ (2012) Structural shifts of fecal microbial communities in rats with acute rejection after liver transplantation. Microb Ecol 64:546–554
Wu ZW, Ling ZX, Lu HF, Zuo J, Sheng JF, Zheng SS, Li LJ (2012) Changes of gut bacteria and immune parameters in liver transplant recipients. Hepatobiliary Pancreat Dis Int 11:40–50
Kamada N, Calne RY (1983) A surgical experience with five hundred thirty liver transplants in the rat. Surgery 93:64–69
Xie YR, Liu SL, Liu X, Luo ZB, Zhu B, Li ZF, Li LJ, He Y, Jiang L, Li H, Ruan B (2011) Intestinal microbiota and innate immunity-related gene alteration in cirrhotic rats with liver transplantation. Transplant Proc 43:3973–3979
Muyzer G, de Waal EC, Uitterlinden AG (1993) Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol 59:695–700
Yu Z, Morrison M (2004) Comparisons of different hypervariable regions of rrs genes for use in fingerprinting of microbial communities by PCR-denaturing gradient gel electrophoresis. Appl Environ Microbiol 70:4800–4806
Xing HC, Li LJ, Xu KJ, Shen T, Chen YB, Sheng JF, Chen Y, Fu SZ, Chen CL, Wang JG, Yan D, Dai FW, Zheng SS (2006) Protective role of supplement with foreign Bifidobacterium and Lactobacillus in experimental hepatic ischemia-reperfusion injury. J Gastroenterol Hepatol 21:647–656
Lefrancois L, Lycke N (2001) Isolation of mouse small intestinal intraepithelial lymphocytes, Peyer’s patch, and lamina propria cells. Curr Protoc Immunol Chapter 3: Unit 3.19
Danielsson A, Hellers G, Lyrenas E, Lofberg R, Nilsson A, Olsson O, Olsson SA, Persson T, Salde L, Naesdal J et al (1987) A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Scand J Gastroenterol 22:987–992
Geboes K, Dalle I (2002) Influence of treatment on morphological features of mucosal inflammation. Gut 50(Suppl 3):III37–III42
Safdar N, Said A, Lucey MR (2004) The role of selective digestive decontamination for reducing infection in patients undergoing liver transplantation: a systematic review and meta-analysis. Liver Transpl 10:817–827
Lepage P, Seksik P, Sutren M, de la Cochetiere MF, Jian R, Marteau P, Dore J (2005) Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis 11:473–480
Seksik P, Lepage P, de la Cochetiere MF, Bourreille A, Sutren M, Galmiche JP, Dore J, Marteau P (2005) Search for localized dysbiosis in Crohn’s disease ulcerations by temporal temperature gradient gel electrophoresis of 16S rRNA. J Clin Microbiol 43:4654–4658. doi:10.1128/JCM.43.9.4654-4658.2005
Perez-Cobas AE, Artacho A, Knecht H, Ferrus ML, Friedrichs A, Ott SJ, Moya A, Latorre A, Gosalbes MJ (2013) Differential effects of antibiotic therapy on the structure and function of human gut microbiota. PLoS One 8:e80201. doi:10.1371/journal.pone.0080201
Quigley EM, Monsour HP (2013) The gut microbiota and the liver: implications for clinical practice. Expert Rev Gastroenterol Hepatol 7:723–732. doi:10.1586/17474124.2013.848167
Gill H, Prasad J (2008) Probiotics, immunomodulation, and health benefits. Adv Exp Med Biol 606:423–454
Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M (2005) Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 174:3237–3246
Pronio A, Montesani C, Butteroni C, Vecchione S, Mumolo G, Vestri A, Vitolo D, Boirivant M (2008) Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells. Inflamm Bowel Dis 14:662–668
Lorea Baroja M, Kirjavainen PV, Hekmat S, Reid G (2007) Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin Exp Immunol 149:470–479
Li YT, Wang L, Chen Y, Chen YB, Wang HY, Wu ZW, Li LJ (2010) Effects of gut microflora on hepatic damage after acute liver injury in rats. J Trauma 68:76–83
Marshall JC, Nathens AB (1996) The gut in critical illness: evidence from human studies. Shock 6(Suppl 1):S10–S16
Ivanov II, Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, Finlay BB, Littman DR (2008) Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4:337–349
Li J, Lai X, Liao W, He Y, Liu Y, Gong J (2011) The dynamic changes of Th17/Treg cytokines in rat liver transplant rejection and tolerance. Int Immunopharmacol 11:962–967
Acknowledgments
This study was supported by the National Keystone Basic Research Program (973 Program), China (2013CB531401, 2007CB513000), and the Fundamental Research Funds for the Central Universities, China (2013XZZX00).
Conflict of Interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Yirui Xie and Huazhong Chen contributed equally to this work.
Rights and permissions
About this article
Cite this article
Xie, Y., Chen, H., Zhu, B. et al. Effect of Intestinal Microbiota Alteration on Hepatic Damage in Rats with Acute Rejection After Liver Transplantation. Microb Ecol 68, 871–880 (2014). https://doi.org/10.1007/s00248-014-0452-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00248-014-0452-z